Cutaneous toxicities from targeted therapies used in oncology: Literature review of clinical presentation and management
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology
Reference55 articles.
1. Aggressive squamous cell carcinoma in a patient on the Janus kinase inhibitor ruxolitinib;Aboul-Fettouh;JAAD Case Rep,2018
2. Systemic retinoids for the chemoprevention of cutaneous squamous cell carcinoma and verrucal keratosis in a cohort of patients on BRAF inhibitors;Anforth;Br J Dermatol,2013
3. Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (CoBRIM): Updated efficacy results from a randomised, double-blind, phase 3 trial;Ascierto;Lancet Oncol,2016
4. Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma;Atkins;J Clin Oncol,2004
5. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial;Basch;J Clin Oncol,2016
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The spectrum of cutaneous toxicities related to novel genitourinary cancer therapies;Critical Reviews in Oncology/Hematology;2024-08
2. Pharmacotherapy of plexiform neurofibromas in patients with neurofibromatosis type 1. Possible adverse events and their management;Russian Journal of Child Neurology;2024-07-17
3. Photoprotection: Current developments and controversies;Journal of the European Academy of Dermatology and Venereology;2024-06-26
4. Skin care in oncology patients;Onkologie;2024-05-03
5. Surveillance of Symptom Burden Using the Patient-Reported Outcome Version of the Common Terminology Criteria for Adverse Events in Patients With Various Types of Cancers During Chemoradiation Therapy: Real-World Study;JMIR Public Health and Surveillance;2023-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3